Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(5)
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
Analyst Buy
|
Strong Performer, Getting Expensive
2219.2000
38.10
(
1.75
%)
NSE
Jul 14, 2025
15:31 PM
New 52W High in past week
Volume:
3.6M
High vol.+gain this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
26 May 2023
Analyst Buy
2219.20
1.75%
GLENMARK PHARMACEUTICALS
Hold:
Glenmark Pharmaceuticals Ltd.
by
Geojit BNP Paribas
Target: 638
Recommendation
Target
Geojit BNP Paribas
Glenmark Pharmaceuticals Ltd. is trading above all available SMAs
More from Glenmark Pharmaceuticals Ltd.
Recommended
IPO spree continues with Anthem and two SME issues opening this week
|
14 Jul 2025, 04:42PM
Market closes lower, Ahluwalia Contracts bags a Rs 2,089 crore order from DLF
Trendlyne Marketwatch |
14 Jul 2025, 03:56PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020